LifeScience Cell & Gene
IASO Bio Receives Second FDA IND Approval in 2024 for Groundbreaking Cell Therapy Eque-cel to Treat Multiple Sclerosis
IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therap...
July 25, 2024 | News
DiscGenics Receives FDA Approval to Proceed with Phase III Clinical Trials for Regenerative Cell Therapy for Lumbar Degenerative Disc Disease
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoske...
July 23, 2024 | News
Agilent Technologies Launches ProteoAnalyzer System at SCGT Summit
Agilent Technologies Inc. announced the release of its new ProteoAnalyzer system, in addition to existing product updates at the Singapore Cell and Ge...
July 22, 2024 | News
ACROBiosystems Launches Resilient Supply Brand to Boost Cell and Gene Therapy Development at ISSCR Annual Meeting
At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Res...
July 19, 2024 | News
University of Pennsylvania Expands Gene Therapy Program with Univercells Technologies to Scale Production
Donaldson, a global provider of innovative biomanufacturing technologies, with its Univercells Technologies business, announces that the Gene Th...
July 18, 2024 | News
Biosyngen's Groundbreaking CAR-T Therapy BRG01 Approved for Phase II Clinical Trial in China
Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation ...
July 17, 2024 | News
Accelerated Biosciences and Pluristyx Achieve Breakthrough in Creating Clinical Grade iPSC Lines Using Novel hTSC Starting Material
Accelerated Biosciences ("Accelerated Bio"), in partnership with Pluristyx, proudly announces the successful creation of clinical grade induced pluripotent...
July 15, 2024 | News
National Cancer Center and University of Pennsylvania License CCR4 CAR-T Cell Therapy to ARC Therapies Inc.
The National Cancer Center (Tokyo, Japan) and The University of Pennsylvania (Philadelphia, PA, USA) have licensed patent rights directed to a ch...
July 12, 2024 | News
Andelyn Biosciences Selected by UMass Chan Medical School to Manufacture AAV9-CSA Vector for Cockayne Syndrome Treatment
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selecte...
July 11, 2024 | News
Innovent and IASO Bio Strengthen Strategic Partnership in Cell Therapy
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
July 08, 2024 | News
Aptamer Group and AstraZeneca Collaborate to Advance Targeted siRNA Delivery for Fibrotic Liver Cells
Aptamer Group , the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce a new agreem...
July 05, 2024 | News
Eisai Reclaims Full Rights to Farletuzumab Ecteribulin After Ending Collaboration with Bristol Myers Squibb
Eisai Co., Ltd. announced that it has agreed to end its global strategic collaboration with Bristol Myers Squibb for the co-development and c...
July 04, 2024 | News
IASO Biotechnology Secures NMPA Approval for IND Application of RD118 CAR-T Therapy Targeting GPRC5D for Relapsed/Refractory Multiple Myeloma
IASO Biotechnology , a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody pr...
July 01, 2024 | News
Advancing Cancer Care: The Promise and Potential of CAR-T Therapy
In an interaction with BioPharma APAC, Anuradha Rajapakse, Senior Director for Value & Access at Gilead and Kite Oncology, This discussion...
June 28, 2024 | Interaction
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
